After opening the day on a weak note, the Indian share markets have continued to trade in the red. Sectoral indices are trading on a negative note with stocks from the consumer durables sector and stocks from the realty sector witnessing maximum selling pressure.
Stocks in the automobile sector are trading in the red with Tata Motors and Escorts leading the losses.
The BSE Sensex is trading down 289 points (down 1%) and the HYPERLINK "https://www.equitymaster.com/india-markets/nse-replica.asp" NSE Nifty is trading down 86 points (down 1%). The BSE Mid Cap index is trading down by 1.1%, while the BSE Small Cap index is trading down 1%. The rupee is trading at 66.83 to the US$.
Financial markets around the world are scrutinizing Federal Minutes of the September 20-21 meeting that were released yesterday. The Fed minutes state that Federal Reserve officials decided only after considerable disagreement to hold interest rates unchanged at their September meeting. While some officials voted for an interest rate hike, others preferred to wait a bit longer in hopes of seeing more improvement in the labor market.
The minutes didn't signal when the next rate increase might come. However, they largely reinforced market expectations of a rate hike in December, after the US presidential election.
The minutes also showed Fed officials didn't see major threats to the US economy. Most of the officials said that the risk to the outlook were balanced. Several of them also indicated that the risk from Brexit had receded.
The major takeaway, as the minutes showed, was a growing disagreement among Fed officials over how much lower the unemployment rate can go before the economy overheats and inflation gets out of hand.
The Federal Reserve has two more policy meetings this year, one in early November and second in mid-December. In their economic projections released last month, 14 of 17 Fed officials indicated they expected to raise rates before the end of this year.
In another news from the domestic stock markets, scrip of drug maker Cipla gained around 3% during the morning trade today as its Indore plant got US FDA clearance. The company has received establishment inspection report (EIR) from the United States Food and Drug Administration (US FDA) for its Indore facility. The EIR indicated the formal closure of inspection conducted in July and August of 2015.
Cipla is one of the top pharmaceutical companies in India. The company is a market leader in three therapies viz. Respiratory, Urology and Antiretroviral (ARV). To know our views on the stock of Cipla, you can read our analysis of the company results (subscription required).
Presently the stock of Cipla is trading up by 1.4%.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Indian Indices Continue Downtrend; Tata Motors Leads the Losses". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!